 Scott Younger
Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rare Diseases | 4 | 2023 | 33 | 2.070 |
Why?
| | Tumor Suppressor Protein p53 | 4 | 2020 | 43 | 1.900 |
Why?
| | MicroRNAs | 4 | 2015 | 27 | 1.690 |
Why?
| | Genomics | 6 | 2022 | 64 | 1.650 |
Why?
| | Gene Expression Regulation | 6 | 2017 | 93 | 1.590 |
Why?
| | CRISPR-Cas Systems | 6 | 2021 | 12 | 1.530 |
Why?
| | Neoplasms | 4 | 2021 | 97 | 1.510 |
Why?
| | RNA, Untranslated | 5 | 2015 | 6 | 1.470 |
Why?
| | Enhancer Elements, Genetic | 3 | 2021 | 15 | 1.240 |
Why?
| | Promoter Regions, Genetic | 5 | 2011 | 47 | 1.220 |
Why?
| | DNA Damage | 2 | 2017 | 6 | 1.200 |
Why?
| | Chromatin | 4 | 2017 | 24 | 1.190 |
Why?
| | Humans | 24 | 2023 | 6129 | 0.840 |
Why?
| | Transcription, Genetic | 2 | 2011 | 44 | 0.820 |
Why?
| | Genetic Association Studies | 1 | 2020 | 31 | 0.790 |
Why?
| | RNA, Long Noncoding | 3 | 2015 | 12 | 0.780 |
Why?
| | Fibroblasts | 2 | 2017 | 26 | 0.780 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 136 | 0.740 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2021 | 25 | 0.720 |
Why?
| | Algorithms | 2 | 2015 | 93 | 0.610 |
Why?
| | Cell Line, Tumor | 8 | 2021 | 58 | 0.580 |
Why?
| | Centromere | 1 | 2015 | 1 | 0.570 |
Why?
| | DNA, Satellite | 1 | 2015 | 1 | 0.570 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2015 | 3 | 0.570 |
Why?
| | Gene Silencing | 3 | 2011 | 11 | 0.530 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2014 | 1 | 0.520 |
Why?
| | Colorectal Neoplasms | 1 | 2014 | 20 | 0.500 |
Why?
| | Animals | 8 | 2021 | 628 | 0.480 |
Why?
| | Binding Sites | 3 | 2020 | 26 | 0.460 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2023 | 88 | 0.450 |
Why?
| | Cell Proliferation | 3 | 2021 | 51 | 0.410 |
Why?
| | Gene Knockout Techniques | 3 | 2020 | 5 | 0.400 |
Why?
| | RNA, Double-Stranded | 2 | 2009 | 2 | 0.380 |
Why?
| | Genes, Tumor Suppressor | 2 | 2021 | 4 | 0.380 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2021 | 112 | 0.380 |
Why?
| | Receptors, Progesterone | 5 | 2011 | 6 | 0.350 |
Why?
| | Cell Line | 4 | 2017 | 70 | 0.340 |
Why?
| | Mice | 6 | 2021 | 291 | 0.340 |
Why?
| | Gene Library | 2 | 2018 | 5 | 0.330 |
Why?
| | 3' Untranslated Regions | 3 | 2015 | 9 | 0.320 |
Why?
| | Genome | 3 | 2022 | 29 | 0.320 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2021 | 14 | 0.300 |
Why?
| | Antineoplastic Agents | 3 | 2021 | 37 | 0.300 |
Why?
| | Precision Medicine | 2 | 2021 | 32 | 0.250 |
Why?
| | DNA Methylation | 1 | 2023 | 110 | 0.220 |
Why?
| | RNA, Small Interfering | 2 | 2015 | 12 | 0.220 |
Why?
| | Smad4 Protein | 1 | 2021 | 1 | 0.210 |
Why?
| | RNA, Antisense | 3 | 2010 | 3 | 0.210 |
Why?
| | Pancreatic Neoplasms | 1 | 2021 | 8 | 0.210 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2021 | 4 | 0.210 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2021 | 1 | 0.210 |
Why?
| | Sequence Analysis, DNA | 3 | 2023 | 106 | 0.210 |
Why?
| | Mutation | 2 | 2021 | 179 | 0.210 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2021 | 2 | 0.210 |
Why?
| | Organ Specificity | 1 | 2020 | 21 | 0.200 |
Why?
| | Biomarkers | 1 | 2020 | 107 | 0.190 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2020 | 2 | 0.190 |
Why?
| | Phenotype | 1 | 2020 | 207 | 0.190 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2019 | 4 | 0.190 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 36 | 0.180 |
Why?
| | Genetic Variation | 1 | 2020 | 140 | 0.180 |
Why?
| | Base Sequence | 3 | 2023 | 77 | 0.180 |
Why?
| | Genome, Human | 1 | 2020 | 73 | 0.180 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2018 | 2 | 0.180 |
Why?
| | Glutathione | 1 | 2019 | 10 | 0.180 |
Why?
| | Cell Survival | 1 | 2019 | 16 | 0.180 |
Why?
| | Antioxidants | 1 | 2019 | 5 | 0.180 |
Why?
| | Retinoblastoma Binding Proteins | 1 | 2018 | 1 | 0.180 |
Why?
| | Aurora Kinase B | 1 | 2018 | 1 | 0.180 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2018 | 2 | 0.180 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2018 | 7 | 0.180 |
Why?
| | Lung Neoplasms | 1 | 2018 | 19 | 0.170 |
Why?
| | Reproducibility of Results | 2 | 2019 | 179 | 0.170 |
Why?
| | Ectopic Gene Expression | 1 | 2018 | 1 | 0.170 |
Why?
| | Lentivirus | 1 | 2018 | 3 | 0.170 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 3 | 0.170 |
Why?
| | RNA Interference | 1 | 2018 | 10 | 0.170 |
Why?
| | RNA | 2 | 2008 | 17 | 0.160 |
Why?
| | Nucleotide Motifs | 1 | 2017 | 2 | 0.160 |
Why?
| | Protein Binding | 1 | 2017 | 27 | 0.160 |
Why?
| | Doxorubicin | 1 | 2017 | 16 | 0.160 |
Why?
| | Fetus | 1 | 2017 | 21 | 0.160 |
Why?
| | Genetic Testing | 1 | 2017 | 74 | 0.160 |
Why?
| | Proteins | 1 | 2015 | 15 | 0.140 |
Why?
| | Cells, Cultured | 1 | 2015 | 70 | 0.140 |
Why?
| | Oligonucleotides | 1 | 2015 | 4 | 0.140 |
Why?
| | Databases, Genetic | 1 | 2015 | 15 | 0.130 |
Why?
| | Models, Genetic | 2 | 2011 | 17 | 0.130 |
Why?
| | RNA, Messenger | 2 | 2010 | 129 | 0.110 |
Why?
| | RNA-Binding Proteins | 1 | 2010 | 4 | 0.100 |
Why?
| | Transcriptional Activation | 1 | 2010 | 8 | 0.100 |
Why?
| | RNA, Small Cytoplasmic | 1 | 2010 | 1 | 0.100 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 86 | 0.090 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2009 | 2 | 0.090 |
Why?
| | Computational Biology | 1 | 2009 | 25 | 0.090 |
Why?
| | Gene Expression | 1 | 2009 | 57 | 0.090 |
Why?
| | Mice, Nude | 2 | 2019 | 10 | 0.090 |
Why?
| | Apoptosis | 2 | 2018 | 48 | 0.080 |
Why?
| | Signal Transduction | 2 | 2018 | 94 | 0.080 |
Why?
| | Gene Expression Profiling | 2 | 2019 | 91 | 0.070 |
Why?
| | Gene Targeting | 2 | 2017 | 5 | 0.070 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 25 | 0.060 |
Why?
| | Haplotypes | 1 | 2023 | 61 | 0.060 |
Why?
| | Pedigree | 1 | 2022 | 52 | 0.050 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 63 | 0.050 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2021 | 3 | 0.050 |
Why?
| | Adenocarcinoma | 1 | 2021 | 5 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2021 | 15 | 0.050 |
Why?
| | Myeloproliferative Disorders | 1 | 2021 | 10 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2021 | 71 | 0.050 |
Why?
| | Disease Progression | 1 | 2021 | 95 | 0.050 |
Why?
| | Female | 2 | 2019 | 3284 | 0.050 |
Why?
| | Genes, Essential | 1 | 2019 | 2 | 0.050 |
Why?
| | Small Molecule Libraries | 1 | 2019 | 5 | 0.050 |
Why?
| | Datasets as Topic | 1 | 2019 | 6 | 0.050 |
Why?
| | Oncogenes | 1 | 2019 | 3 | 0.050 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 11 | 0.050 |
Why?
| | DNA, Complementary | 2 | 2010 | 9 | 0.050 |
Why?
| | Glutamate-Cysteine Ligase | 1 | 2019 | 1 | 0.050 |
Why?
| | Mammary Glands, Animal | 1 | 2019 | 1 | 0.050 |
Why?
| | Thiocyanates | 1 | 2019 | 1 | 0.050 |
Why?
| | Mammary Glands, Human | 1 | 2019 | 1 | 0.050 |
Why?
| | Ubiquitinated Proteins | 1 | 2019 | 1 | 0.050 |
Why?
| | Buthionine Sulfoximine | 1 | 2019 | 2 | 0.050 |
Why?
| | MCF-7 Cells | 1 | 2019 | 2 | 0.050 |
Why?
| | Organoids | 1 | 2019 | 2 | 0.050 |
Why?
| | Catalytic Domain | 1 | 2019 | 5 | 0.050 |
Why?
| | Aminopyridines | 1 | 2019 | 2 | 0.050 |
Why?
| | Tumor Burden | 1 | 2019 | 3 | 0.050 |
Why?
| | Oxidative Stress | 1 | 2019 | 13 | 0.040 |
Why?
| | Chromosome Segregation | 1 | 2018 | 2 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 19 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2018 | 16 | 0.040 |
Why?
| | Transduction, Genetic | 1 | 2018 | 3 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2017 | 4 | 0.040 |
Why?
| | Machine Learning | 1 | 2017 | 14 | 0.040 |
Why?
| | Streptococcus pyogenes | 1 | 2017 | 13 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2017 | 19 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2015 | 28 | 0.030 |
Why?
| | Child | 1 | 2022 | 3004 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2010 | 7 | 0.020 |
Why?
| | 5' Untranslated Regions | 1 | 2010 | 2 | 0.020 |
Why?
| | Protein Conformation | 1 | 2010 | 4 | 0.020 |
Why?
| | BRCA1 Protein | 1 | 2010 | 3 | 0.020 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2008 | 1 | 0.020 |
Why?
| | Biotin | 1 | 2008 | 2 | 0.020 |
Why?
| | RNA Polymerase II | 1 | 2008 | 3 | 0.020 |
Why?
| | Genetic Techniques | 1 | 2008 | 5 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 84 | 0.020 |
Why?
| | Deoxyadenosines | 1 | 2007 | 1 | 0.020 |
Why?
| | Thionucleosides | 1 | 2007 | 1 | 0.020 |
Why?
| | Peptide Nucleic Acids | 1 | 2007 | 1 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2007 | 2 | 0.020 |
Why?
| | Hormones | 1 | 2007 | 2 | 0.020 |
Why?
| | Hydroxamic Acids | 1 | 2007 | 2 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2007 | 2 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2007 | 19 | 0.020 |
Why?
| | Blotting, Western | 1 | 2007 | 27 | 0.020 |
Why?
| | Up-Regulation | 1 | 2007 | 26 | 0.020 |
Why?
| | Histones | 1 | 2007 | 30 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 80 | 0.020 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|